Estrogen [EPC]

160084 reported adverse events

Drugs of this class: ESTRADIOL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL ETONOGESTREL AND ETHINYL ESTRADIOL ESTRADIOL AND NORETHINDRONE ACETATE AGNUS CASTUS, AMBRA GRISEA, PETROSELINUM SATIVUM, ESTRADIOL, L-DOPA, MELATONIN, TESTOSTERONE, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, SARCOLACTICUM ACIDUM, UBIDECARENONUM, BARYTA CARBONICA, CONIUM MACULATUM, SELENIUM METALLICUM, FOLLICULINUM, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HYPOTHALAMUS SUIS, LYMPH NODE (SUIS), MEDULLA OSSIS SUIS, OOPHORINUM (SUIS), ORCHITINUM (SUIS), PANCREAS SUIS, SPLEEN (SUIS), HUMAN GROWTH HORMONE, LEVONORGESTREL AND ETHINYL ESTRADIOL ESTRADIOL/NORETHINDRONE ACETATE NORELGESTROMIN AND ETHINYL ESTRADIOL CONJUGATED ESTROGENS CONJUGATED ESTROGENS/BAZEDOXIFENE ESTRADIOL AND PROGESTERONE

These side effects are most commonly reported by patients taking drugs of the Estrogen [EPC] class:

#	Side effect	Count
0	BREAST CANCER	12651
1	BREAST CANCER FEMALE	11025
2	DRUG INEFFECTIVE	10907
3	HEADACHE	8178
4	NAUSEA	7888
5	OFF LABEL USE	7340
6	FATIGUE	6811
7	PAIN	5879
8	PULMONARY EMBOLISM	5041
9	DIZZINESS	4870

See all common reactions for Estrogen [EPC]

Drugs of the Estrogen [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	VAGINAL CONTRACEPTIVE DEVICE EXPELLED	140	1.0000
1	CONTRALATERAL BREAST CANCER	165	0.8010
2	PROGESTERONE RECEPTOR ASSAY POSITIVE	718	0.7720
3	OESTROGEN RECEPTOR ASSAY POSITIVE	832	0.7462
4	OESTRADIOL DECREASED	164	0.6029
5	VAGINAL MYCOSIS	126	0.5408
6	BREAST CANCER IN SITU	615	0.5004
7	VENA CAVA FILTER INSERTION	137	0.4597
8	BREAST CANCER FEMALE	11025	0.4512
9	BLOOD OESTROGEN DECREASED	205	0.3789

See all enriched reactions for Estrogen [EPC]